232 related articles for article (PubMed ID: 35562811)
21. Cancers associated with human gammaherpesviruses.
Wen KW; Wang L; Menke JR; Damania B
FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
[TBL] [Abstract][Full Text] [Related]
22. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
23. KSHV/HHV8-mediated hematologic diseases.
Cesarman E; Chadburn A; Rubinstein PG
Blood; 2022 Feb; 139(7):1013-1025. PubMed ID: 34479367
[TBL] [Abstract][Full Text] [Related]
24. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
Aguirre AJ; Robertson ES
J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
[TBL] [Abstract][Full Text] [Related]
26. Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2.
Shrestha P; Davis DA; Jaeger HK; Stream A; Aisabor AI; Yarchoan R
PLoS Pathog; 2021 Jan; 17(1):e1009091. PubMed ID: 33411730
[TBL] [Abstract][Full Text] [Related]
27. Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.
Gorres KL; Daigle D; Mohanram S; Miller G
J Virol; 2014 Jul; 88(14):8028-44. PubMed ID: 24807711
[TBL] [Abstract][Full Text] [Related]
28. Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
Böni M; Rieble L; Münz C
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560713
[TBL] [Abstract][Full Text] [Related]
29. Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.
Tomescu C; Law WK; Kedes DH
J Virol; 2003 Sep; 77(17):9669-84. PubMed ID: 12915579
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
[TBL] [Abstract][Full Text] [Related]
31. Rewiring of the Host Cell Metabolome and Lipidome during Lytic Gammaherpesvirus Infection Is Essential for Infectious-Virus Production.
Clark SA; Vazquez A; Furiya K; Splattstoesser MK; Bashmail AK; Schwartz H; Russell M; Bhark SJ; Moreno OK; McGovern M; Owsley ER; Nelson TA; Sanchez EL; Delgado T
J Virol; 2023 Jun; 97(6):e0050623. PubMed ID: 37191529
[TBL] [Abstract][Full Text] [Related]
32. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A
Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748
[TBL] [Abstract][Full Text] [Related]
33. Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma.
Paul AG; Sharma-Walia N; Chandran B
PLoS One; 2011; 6(9):e24379. PubMed ID: 21980345
[TBL] [Abstract][Full Text] [Related]
34. [EBV/KSHV co-infection: an effective partnership].
Gruffat H; Manet E
Med Sci (Paris); 2018 Jan; 34(1):79-82. PubMed ID: 29384100
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
Gregory CD; Murray RJ; Edwards CF; Rickinson AB
J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508
[TBL] [Abstract][Full Text] [Related]
36. Study on the role of G1 cyclins in Epstein-Barr virus-associated human lymphomas maintained in severe combined immune deficiency (SCID) mice.
Murai Y; Dobashi Y; Okada E; Ishizawa S; Shiota M; Mori S; Takano Y
Int J Cancer; 2001 Apr; 92(2):232-9. PubMed ID: 11291051
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.
Sanchez-Martin D; Uldrick TS; Kwak H; Ohnuki H; Polizzotto MN; Annunziata CM; Raffeld M; Wyvill KM; Aleman K; Wang V; Marshall VA; Whitby D; Yarchoan R; Tosato G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376153
[TBL] [Abstract][Full Text] [Related]
38. Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?
Aligo J; Walker M; Bugelski P; Weinstock D
J Immunotoxicol; 2015; 12(1):1-15. PubMed ID: 24512328
[TBL] [Abstract][Full Text] [Related]
39. Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo.
Feldman ER; Kara M; Coleman CB; Grau KR; Oko LM; Krueger BJ; Renne R; van Dyk LF; Tibbetts SA
mBio; 2014 May; 5(3):e00981-14. PubMed ID: 24865551
[TBL] [Abstract][Full Text] [Related]
40. Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells.
Matthews NC; Goodier MR; Robey RC; Bower M; Gotch FM
Eur J Immunol; 2011 Jul; 41(7):1958-68. PubMed ID: 21509779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
